Research ArticleBasic Science Investigations
Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts
Michiel Bolkestein, Erik de Blois, Stuart J. Koelewijn, Alexander M.M. Eggermont, Frank Grosveld, Marion de Jong and Gerben A. Koning
Journal of Nuclear Medicine April 2016, 57 (4) 601-607; DOI: https://doi.org/10.2967/jnumed.115.166173
Michiel Bolkestein
1Laboratory of Experimental Surgical Oncology, Department of Surgery, Erasmus MC, Rotterdam, The Netherlands
Erik de Blois
2Departments of Nuclear Medicine and Radiology, Erasmus MC, Rotterdam, The Netherlands
Stuart J. Koelewijn
2Departments of Nuclear Medicine and Radiology, Erasmus MC, Rotterdam, The Netherlands
Alexander M.M. Eggermont
3Gustave Roussy Cancer Campus Grand Paris, Villejuif Paris, France; and
Frank Grosveld
4Department of Cell Biology, Erasmus MC, Rotterdam, The Netherlands
Marion de Jong
2Departments of Nuclear Medicine and Radiology, Erasmus MC, Rotterdam, The Netherlands
Gerben A. Koning
1Laboratory of Experimental Surgical Oncology, Department of Surgery, Erasmus MC, Rotterdam, The Netherlands

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 4
April 1, 2016
Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts
Michiel Bolkestein, Erik de Blois, Stuart J. Koelewijn, Alexander M.M. Eggermont, Frank Grosveld, Marion de Jong, Gerben A. Koning
Journal of Nuclear Medicine Apr 2016, 57 (4) 601-607; DOI: 10.2967/jnumed.115.166173
Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts
Michiel Bolkestein, Erik de Blois, Stuart J. Koelewijn, Alexander M.M. Eggermont, Frank Grosveld, Marion de Jong, Gerben A. Koning
Journal of Nuclear Medicine Apr 2016, 57 (4) 601-607; DOI: 10.2967/jnumed.115.166173
Jump to section
Related Articles
Cited By...
- Assessing Tumor Microenvironment Characteristics and Stratifying EPR with a Nanobubble Companion Nanoparticle via Contrast-Enhanced Ultrasound Imaging
- MRI techniques for immunotherapy monitoring
- Spatial Transcriptomics-based Identification of Molecular Markers for Nanomedicine Distribution in Tumor Tissue
- An Antibody-Tumor Necrosis Factor Fusion Protein that Synergizes with Oxaliplatin for Treatment of Colorectal Cancer
- Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers